发明名称 A cyclohexane polyalcohol formulation for treatment of disorders of protein aggregation
摘要 Disclosed herein is a dosage form for administering a dose of 500mg scyllo-inositol to a subject, which are suitable for oral administration, for use in the prevention, treatments or control of symptoms of a disorder in protein folding and/or aggregation, and/or amyloid formation, deposition, accumulation, or persistence, wherein the effective dose to be administered comprises scyllo-inositol in a dosage form selected from the group consisting of tablets, capsules, lozenges, gelcaps, buccal patches, suspensions, solutions, gels and drug matrix compositions to effect the sustained release of the scyllo-inositol and drug matrix compositions to effect the rapid release of scyllo-inositol.
申请公布号 NZ571181(A) 申请公布日期 2011.12.22
申请号 NZ20070571181 申请日期 2007.03.09
申请人 WARATAH PHARMACEUTICALS INC.;JOANNE MCLAURIN 发明人 MCLAURIN, JOANNE;CRUZ, ANTONIO
分类号 A61K31/047;A61P25/28 主分类号 A61K31/047
代理机构 代理人
主权项
地址